Cannabis trialled as melanoma treatment by University of Canberra

Researchers at the University of Canberra will collaborate with a pharmaceutical company to test the efficacy of medicinal cannabis in treating melanoma.

The university announced a $1 million deal with Israel-based Cann Pharmaceutical to provide specific medical-grade strains of cannabis, which will be administered to patients along with the current standard of care for melanoma patients.

Molecular and cellular biology professor Sudha Rao said the research could benefit the almost-55,000 Australians that live with the skin cancer.

"Australians have the highest rate of melanoma in the world, with estimates of more than 13,000 new cases to be diagnosed in 2016 alone," she said.


Availability of Medical Cannabis in Israel to Reach an All-time High

The government has approved a plan that will remove many of the restrictions on growing medical marijuana and make it more readily available to over 23,000 patients in Israel.

According to the proposal, initiated by Health Minister Yaakov Litzman (United Torah Judaism), there will be no limit on the number of growers, there will be more doctors who can issue prescriptions, and cannabis will be available in pharmacies.


New Israeli Cannabis Farmers Continue to Fight for Growing License

Although Israel is one of the leaders in medical cannabis research, Israel is behind other countries in creating legal outlines for its use, both medical and recreational.

A number of farmers who would like to become legal cannabis growers petitioned the Jerusalem District Court on Sunday to force the state to make a decision on licensing requirements.

Currently, there are eight approved cannabis-growing companies in Israel. The plaintiffs, represented by attorney Hagit Weinstock, complain that the companies were chosen years ago without a tender, and that farmers who want to enter the market are finding themselves at a dead-end.


Medical Marijuana Study Shows Stunning Effect On Treating Pain, Nausea

Israel’s medical marijuana program is a stunning success when it comes to treating people for pain and nausea, according to a study presented at the International Jerusalem Conference on Health Policy.

The study, released May 26, is the first its kind examining cancer and non-cancer patients who’ve been given permission by Israel’s health ministry to use marijuana for treatment.

Lead researcher Prof. Pesach Shvartzman of Ben-Gurion University of the Negev’s Health Sciences Faculty said the vast majority of patients reported the drug helped relieve pain and nausea.


Israel: Cabinet vote on decriminalizing cannabis delayed a week

A vote on a bill to decriminalize possession of small amounts of marijuana has been delayed a week due to opposition from Public Security Minister Gilad Erdan and Health Minister Yaakov Litzman.

The legislation was scheduled to come up for a vote in the Ministerial Committee for Legislation on Sunday, but opposition from two key ministers responsible for enforcing it has led one of its authors, Likud’s MK Sharren Haskel, to delay the vote “in order to reach an agreement with my faction colleague” Erdan.


Israel Justice minister mulls decriminalizing cannabis

Justice minister suggests fines will replace criminal proceedings, while local report says ministers will vote Sunday on draft bill

The Justice Ministry is exploring the possibility of Israel decriminalizing the use of soft drugs such as cannabis, Justice Minister Ayelet Shaked said Wednesday.

Shaked told Army Radio said that under potential guidelines, those caught using soft drugs would have to pay a fine, but it would no longer be considered a criminal act.


Israel: Decriminalization of marijuana - coming soon?

Justice Minister Ayelet Shaked (Jewish Home) is seeking alternatives to legislature that would completely decriminalize the personal use of soft drugs, Walla! News reports Wednesday, following a debate over a similar bill proposed by Meretz MK Tamar Zandberg. 

Representatives of the Ministry of Justice confirmed that Shaked turned to the Ministry's internal legal advisory office to examine an alternative to de-criminalization of the drugs. 

The amount of drugs allowed for personal use, according to the proposed law, is 15 grams, and applies to hashish and marijuana; the law would commute the fines for personal use, which top hundreds of shekels. In this case, the penalty for the offense would be reduced significantly, although usage itself is banned. 


Israeli Medical Cannabis Company to Build New Mexico Plant

Panaxia has devised a method of extracting precise dosages of medical cannabis.

Israel generic drugs and medical devices company Panaxia has signed an agreement with Ultra Health, the leading medical cannabis distribution company in New Mexico, to build a cannabis processing plant. The plant will be built on one of Ultra Health's farms in New Mexico, and its products will be marketed in the US by Ultra Health.

Panaxia said that the six-month pilot project would include a commitment to buying merchandise for $250,000. Ultra Health operates in five US states besides New Mexico, providing potential growth for Panaxia's business. At the same time, Panaxia is also negotiating similar agreements with other US growers.


Israel: Most medical marijuana users benefit from treatment, finds first-of-its-kind study

The first study on the characteristics of patients with Health Ministry permission for treatment with medical marijuana – until now an unknown field – was revealed on Wednesday at the Sixth International Jerusalem Conference on Health Policy.

The conference was organized by the Israel National Institute for Health Policy Research.

The study was led by Prof. Pesach Shvartzman of Ben-Gurion University of the Negev’s Health Sciences Faculty, who said even though medical cannabis has been legal for a decade and is licensed to more than 20,000 patients for relieving pain and other symptoms, “there has been no information about the users themselves.”


Cutting-edge findings in cannabis research

New evidence for the clinical efficacy of cannabis therapy is presented in the latest issue of the Journal of Basic and Clinical Physiology and Pharmacology (JBCPP), a De Gruyter publication. The authors have studied cannabis therapy for many years at international research centers, examining its effects, potential applications, and risks.


Subscribe to RSS - Israel